PRAX — Praxis Precision Medicines Balance Sheet
0.000.00%
- $6.72bn
- $6.42bn
- $8.55m
Annual balance sheet for Praxis Precision Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 297 | 276 | 100 | 81.3 | 393 |
| Prepaid Expenses | |||||
| Total Current Assets | 302 | 287 | 111 | 84.9 | 404 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.836 | 4.87 | 3.87 | 2.65 | 1.36 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 303 | 293 | 115 | 87.9 | 483 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15.7 | 38.4 | 34.3 | 15.7 | 37.5 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.7 | 41.9 | 39 | 18.3 | 37.7 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 287 | 251 | 76.1 | 69.7 | 445 |
| Total Liabilities & Shareholders' Equity | 303 | 293 | 115 | 87.9 | 483 |
| Total Common Shares Outstanding |